As of Apr 20
| -0.05 / -2.04%|
The 3 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 4.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +66.67% increase from the last price of 2.40.
The current consensus among 5 polled investment analysts is to Hold stock in aTyr Pharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.